Clinical Trials Browser

Phase 2 × Breast Neoplasms × Naltrexone × Clear all

NCT04499950 2025-03-06

A-NEW

Phase 2 Completed

53 enrolled 14 charts

Breast Neoplasms, Obesity, Overweight

NCT00379197 2017-12-28

Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer

Phase 2 Terminated

13 enrolled 4 charts

Breast Neoplasms